Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, Год журнала: 2025, Номер unknown, С. 189336 - 189336
Опубликована: Апрель 1, 2025
Язык: Английский
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, Год журнала: 2025, Номер unknown, С. 189336 - 189336
Опубликована: Апрель 1, 2025
Язык: Английский
The Lancet Oncology, Год журнала: 2025, Номер 26(3), С. e126 - e126
Опубликована: Март 1, 2025
Язык: Английский
Процитировано
1Journal of Histotechnology, Год журнала: 2025, Номер unknown, С. 1 - 6
Опубликована: Фев. 4, 2025
Язык: Английский
Процитировано
0Cancers, Год журнала: 2025, Номер 17(5), С. 801 - 801
Опубликована: Фев. 26, 2025
This review comprehensively analyzes the current landscape of tumor-agnostic therapies in oncology. Tumor-agnostic are designed to target specific molecular alterations rather than primary site tumor, representing a shift cancer treatment. We discuss recent approvals by regulatory agencies such as FDA and EMA, highlighting that have demonstrated efficacy across multiple types sharing common alterations. delve into trial methodologies underpin these approvals, emphasizing innovative designs basket trials umbrella trials. These present unique advantages, including increased efficiency patient recruitment ability assess drug diverse populations rapidly. However, they also entail certain challenges, need for robust biomarkers complexities requirements. Moreover, we examine promising prospects developing rare cancers exhibit targets typically associated with more prevalent malignancies. By synthesizing insights, this underscores transformative potential It offers pathway personalized treatment transcends conventional histology-based classification.
Язык: Английский
Процитировано
0Cancer Cell, Год журнала: 2025, Номер 43(3), С. 380 - 397.e7
Опубликована: Март 1, 2025
Cancer development involves the co-evolution of cancer cells and their surrounding microenvironment, yet dynamics this interaction within physical architecture remains poorly understood. Here, we present a spatial transcriptomic map at single-cell resolution, encompassing 127 multi-stage fields view from 43 patients, to chart evolutionary trajectories human esophageal squamous cell carcinoma (ESCC). By analyzing 6.4 million cells, reveal that ESCC progression is driven by proliferative epithelial subpopulation acquires dedifferentiated invasive characteristics. At late precancerous stage, these disrupt epithelial-stromal interface recruit normal fibroblasts via JAG1-NOTCH1 signaling, transforming them into cancer-associated (CAFs). This leads formation "CAF-Epi" (CAF cell) niche tumor edge shields immune surveillance. The CAF-Epi key indicator in other carcinomas patient outcomes.
Язык: Английский
Процитировано
0Journal of Translational Medicine, Год журнала: 2025, Номер 23(1)
Опубликована: Апрель 11, 2025
Язык: Английский
Процитировано
0Cancer Cell, Год журнала: 2025, Номер 43(4), С. 708 - 727
Опубликована: Апрель 1, 2025
Язык: Английский
Процитировано
0Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, Год журнала: 2025, Номер unknown, С. 189336 - 189336
Опубликована: Апрель 1, 2025
Язык: Английский
Процитировано
0